'Cancer Pharmacogenomics and Targeted Therapies', Cambridge, UK
16 October 2013 - 16 October 2013
United Kingdom
An event entitled 'Cancer Pharmacogenomics and Targeted Therapies' will be held from 15 to 17 September 2013 in Cambridge, UK.
The development of new cancer therapies is increasingly guided by our understanding of the molecular basis of cancer. As worldwide efforts are beginning to provide a comprehensive description of the genomic, transcriptomic and epigenomic changes that occur because of cancer, the field of cancer pharmacogenomics will be at the forefront of a new generation of rationally-designed cancer therapies incorporating molecular biomarkers.
The conference will be an opportunity for scientists and clinician-scientists in academia or industry to share and exchange views on the latest trends and developments. It will also seek to address many of the key challenges in design, development and clinical implementation of targeted cancer therapies.For further information, please visit:
http://registration.hinxton.wellcome.ac.uk/display_info.asp?id=348(opens in new window)
The development of new cancer therapies is increasingly guided by our understanding of the molecular basis of cancer. As worldwide efforts are beginning to provide a comprehensive description of the genomic, transcriptomic and epigenomic changes that occur because of cancer, the field of cancer pharmacogenomics will be at the forefront of a new generation of rationally-designed cancer therapies incorporating molecular biomarkers.
The conference will be an opportunity for scientists and clinician-scientists in academia or industry to share and exchange views on the latest trends and developments. It will also seek to address many of the key challenges in design, development and clinical implementation of targeted cancer therapies.For further information, please visit:
http://registration.hinxton.wellcome.ac.uk/display_info.asp?id=348(opens in new window)